secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenon Pharmaceuticals Inc. (XENE)
CIK:        0001582313
Form:       8-K
Filed at:   2024-04-19T23:59:59+00:00
Accession:  0000950170-24-046023
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Xenon Pharmaceuticals chair Simon Pimstone and director Mohammad Azab not standing for re-election
--------------------------------------------------------------------------------

- Chair Simon Pimstone and board member Mohammad Azab will not stand for re-election at 2024 annual meeting.
- Both directors will continue to serve until the AGM; departures are not due to any disagreement with company.
- No replacements announced yet; board size and composition will change after AGM.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582313/000095017024046023/0000950170-24-046023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582313/000095017024046023/xene-20240415.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-046023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer